Your browser doesn't support javascript.
loading
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
Hoogendoorn, Martine; Feenstra, Talitha L; Asukai, Yumi; Briggs, Andrew H; Hansen, Ryan N; Leidl, Reiner; Risebrough, Nancy; Samyshkin, Yevgeniy; Wacker, Margarethe; Rutten-van Mölken, Maureen P M H.
Affiliation
  • Hoogendoorn M; Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: hoogendoorn@imta.eur.nl.
  • Feenstra TL; Department for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Epidemiology, University Medical Centre Groningen, Groningen, The Netherlands.
  • Asukai Y; IMS Health, Economics and Outcomes Research and Real-World Evidence Solutions, London, UK.
  • Briggs AH; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Hansen RN; Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA.
  • Leidl R; Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich, Neuherberg, Germany.
  • Risebrough N; ICON Health Economics, Toronto, Ontario, Canada.
  • Samyshkin Y; IMS Health, Economics and Outcomes Research and Real-World Evidence Solutions, London, UK.
  • Wacker M; Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich, Neuherberg, Germany.
  • Rutten-van Mölken MP; Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands.
Value Health ; 20(3): 397-403, 2017 Mar.
Article in En | MEDLINE | ID: mdl-28292484

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Cost-Benefit Analysis / Pulmonary Disease, Chronic Obstructive / Salmeterol Xinafoate / Tiotropium Bromide / Fluticasone Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchodilator Agents / Cost-Benefit Analysis / Pulmonary Disease, Chronic Obstructive / Salmeterol Xinafoate / Tiotropium Bromide / Fluticasone Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2017 Document type: Article